Elsevier

Epilepsy Research

Volume 23, Issue 2, March 1996, Pages 95-104
Epilepsy Research

Research report
Effect of para-aminohippurate on the efflux of valproic acid from the central nervous system of the rabbit

https://doi.org/10.1016/0920-1211(95)00092-5Get rights and content

Abstract

Recently we investigated the mechanisms mediating the transport of valproic acid (VPA) between blood and brain. In one study efflux of valproic acid (VPA) from rabbit brain was inhibited by probenecid. Efflux of VPA decreased when probenecid was given intravenously but not when probenecid was given by ventriculocisternal (VC) perfusion indicating that the major site of probenecid-sensitive transport was at the brain capillary endothelium and not at the choroid plexus. In another study VPA transport into rat brain was inhibited by para-aminohippurate (PAH). The purpose of the present study were to determine (a) if the efflux of VPA from rabbit brain was also inhibited by PAH, and (b) whether efflux of VPA could occur at the choroid plexus via an PAH-selective transport system. Six control rabbits received VPA by intravenous infusion and tracer concentrations of [3H]VPA and [14H]PAH by VC perfusion. Rabbits in the PAH group (n = 6) received identical treatment with VPA, tracer concentrations of [3H]VPA and [14C]PAH and, in addition, received 20 mM PAH by VC perfusion. PAH had no effect on the VC extraction ratio of [3H]VPA or the steady-state brain concentration of intravenously administered VPA. It is concluded that the efflux of VPA at the rabbit blood-brain barrier is mediated by a transporter different from the PAH-like transporter responsible for the uptake of VPA into rat brain. In addition, the finding that VC perfusion with PAH had no effect on the VC extraction of [3H]VPA provides further evidence that the choroid plexus plays a negligible role in removal of VPA from the CNS.

References (35)

  • D.D. Shen et al.

    Low and variable presence of valproic acid in human brain

    Neurology

    (1992)
  • H. Nau et al.

    Valproic acid: Brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse

    J. Pharmacol. Exp. Ther.

    (1982)
  • W. Löscher et al.

    Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment

    J. Pharmacol. Exp. Ther.

    (1983)
  • R.L.O. Semmes et al.

    Comparative pharmacodynamics and brain distribution of E-Δ2-valproate and valproate in rats

    Epilepsia

    (1991)
  • K.D.K. Adkison et al.

    Contribution of probenecid-sensitive anion transport processes at the choroidal epithelium and brain capillary endothelium to the efficient removal of valproic acid from the CNS

    J. Pharmacol. Exp. Ther.

    (1994)
  • K.D.K. Adkison et al.

    Uptake of valproic acid into rat brain is mediated by a medium- and long-chain fatty acid transporter

    J. Pharmacol. Exp. Ther.

    (1995)
  • E.H. Baramy

    Inhibition by hippurate and probenecid of in vitro uptake of iodipamide and O-iodohippurate: A composite uptake system for iodipamide in choroid plexus, kidney cortex and anterior uvea of several species

    Acta Physiol. Scand.

    (1972)
  • Cited by (13)

    • Drug efflux transporters in the CNS

      2003, Advanced Drug Delivery Reviews
    View all citing articles on Scopus
    View full text